Price Target Changed Insights You Should Watch Now

 StocksRunner
 
  StocksRunner
 
Follow  Message
 
 
 
Find out what happening right now and get all the pieces of the puzzle on important data activity before the major news sources break the story and see what are the trends
 

•  11 Nov 2025
 

•   AER  
   
  0.00%
•   ANAB  
   
  0.00%
•   APO  
   
  0.00%
•   ASML  
   
  0.00%
•   ATEC  
   
  0.00%

$AER AerCap Holdings remains on Morgan Stanley’s radar with an Equal-Weight rating and a slight downside to its $133.86 target as shares trade near $136.17.

$ANAB AnaptysBio holds steady under Truist Securities with a Hold rating, yet analysts see potential upside to $38.20 from the current $33.56.

$APO Apollo Global Management sees its price target lifted to $133.75 following a strong Q3 and upbeat outlook, pushing shares higher by 1.49%.

$ASML ASML Holding has reached an analyst target of $1522.91, trading at $1022.32, leaving room for careful consideration as traders weigh next moves.

$ATEC Alphatec Holdings stays under Morgan Stanley’s Equal-Weight guidance with a target of $19.72 while the stock trades slightly higher at $20.72.

$ATMU Atmus Filtration Technologies holds a Neutral rating from JP Morgan with a price forecast of $48.59 versus the current $50.00.

$AVB AvalonBay Communities maintains a Neutral outlook from UBS with a bullish $220.89 target, suggesting a 24% potential upside from $178.84.

$BKD Brookdale Senior Living remains an Equal-Weight pick at Barclays, with the $9.27 target indicating downside from its $10.21 trading price.

$BLND Blend Labs keeps its Neutral stance from UBS, with a 64.9% potential upside toward $4.37 from the current $3.00.

$BLSH ish earns an upgrade to Buy from Clear Street, signaling upside to $67.91 as the stock trades near $45.39.

$BMBL Bumble remains Neutral under both UBS and Susquehanna, eyeing a $6.09 target from $4.00.

$CAT Caterpillar rises with HSBC upgrading to Buy and raising the target to $660 from $405, highlighting strong power demand despite a current price of $567.93.

$CCJ Cameco starts coverage at UBS with Neutral and an upside target of $185.57 from $92.52.

$CGC Canopy Growth moves up from Sell to Hold at Benchmark, with upside potential of 109.89% to $2.19 from $1.20.

$CIEN Ciena stays In-Line under Evercore ISI with a price target suggesting 30.3% downside from $207.43 toward $333.78.

$COGT Cogent Biosciences has crossed above analyst targets, trading at $33.42 versus the prior $16.57 target.

$CRWV CoreWeave holds Neutral from B of A Securities, with upside to $139.48 from the current $88.39.

$DCBO Docebo keeps an Equal-Weight rating at Morgan Stanley with a target of $47.01 as shares trade at $23.55.

$ED Consolidated Edison remains Underweight under Barclays with modest upside to $106.55 from $99.59.

$EQR Equity Residential trades near $60.50 with Wells Fargo maintaining an Equal-Weight rating and a target of $63.42.

$EXPD Expeditors sees its price target lifted slightly to $138.60 by Stifel, trading near $139.51 on operational consistency.

$GAP Gap retains a Neutral stance at UBS with a modest upside to $24.38 from $24.02.

$GSL Global Ship Lease has reached analyst targets around $33.02, currently trading at $34.23, prompting potential reevaluation.

$HIW Highwoods Properties trades at $29.25, Wells Fargo maintains Equal-Weight with upside to $32.21.

$HSY Hershey is guided Neutral by DA Davidson with a $193.45 target from $172.72, showing 15% potential upside.

$IMCR Immunocore Holdings retains an Equal-Weight at Morgan Stanley, with shares near $35.20 and upside toward $37.20.

$INDI indie Semiconductor stays Neutral under UBS with an upside to $6.00 from $4.15.

$IRWD Ironwood Pharmaceuticals faces a 61.7% downside forecast at Wells Fargo, trading at $2.89 versus a $2.06 target.

$KVUE Kenvue trades at $16.72, Barclays holds Equal-Weight with a $21.38 target.

$LI Li Auto starts coverage at Piper Sandler with Neutral and a target of $24.36 from $20.42.

$LINE Lineage maintains In-Line under Evercore ISI, trading at $34.56 with potential upside to $50.57.

$LMND Lemonade remains Underweight at Morgan Stanley with substantial downside forecast to $247.65 from $79.14.

$LNTH Lantheus Holdings retains Hold at Truist with an upside toward $58.13 from $53.37.

$LOW Lowes sees its price target nudged to $288.56 by Bernstein, trading at $235.34 ahead of Q3 earnings optimism.

$LVS Las Vegas Sands surpasses analyst targets around $51.67, currently trading at $66.99.

$MAA Mid-America Apartment upgraded to Neutral at UBS, trading at $131.50 with upside to $160.78.

$MDLZ Mondelez holds Neutral at DA Davidson with potential to $74.11 from $57.12.

$META Meta Platforms upgraded to Buy at Freedom Capital Markets, seeing upside to $1046.81 from $627.08.

$MKTX MarketAxess retains Equal-Weight at Barclays with target $222.97 from $171.40.

$MOS Mosaic trades at $25.71, with Wells Fargo maintaining Equal-Weight and a $41.03 target.

$NRDS NerdWallet holds Equal-Weight at Morgan Stanley with minimal upside to $12.07 from $14.50.

$NUE Nucor has its price target lifted to $180 by Citi, trading at $144.02, reflecting strong dividend growth potential.

$NVS Novartis crosses analyst target at $127.11 with upside to $182.09.

$NVTS Navitas Semiconductor hits target pricing at $11.13 while maintaining Neutral ratings from Rosenblatt.

$NXPI NXP Semiconductors sees a slight target lift to $241.68, trading at $202.86 under JP Morgan’s cautious optimism.

$OLPX Olaplex Holdings maintains Equal-Weight at Barclays, with upside to $1.30 from $1.14.

$OSCR Oscar Health remains Underweight at Barclays, target $21.96 from $14.85.

$OWL Blue Owl Capital keeps Outperform rating with a $23.82 target from $15.08.

$PLTR Palantir crosses above its $191.44 target, currently trading at $190.96 versus an analyst peak of $422.11.

$PPG PPG Industries sees a slight trim in price target to $118, trading at $95.90.

$PRVA Privia Health holds Equal-Weight at Barclays with upside to $31.04 from $24.32.

$QRVO Qorvo upgraded to Neutral by Mizuho, targeting $97.42 from $86.52.

$RIG Transocean hits its $4.11 target, trading near $4.22.

$RUN Sunrun upgraded to Buy at Guggenheim, eyeing $25.17 from $19.75.

$SG Sweetgreen maintains Equal-Weight with upside to $14.29 from $5.23.

$SGHT Sight Sciences holds Equal-Weight at Morgan Stanley, target $4.51 from $7.04.

$SNDK Sandisk retains Equal-Weight at Barclays with downside to $216.50 from $271.58.

$STAG STAG Industrial trades at $39.43, with Equal-Weight from Wells Fargo and a target of $38.78.

$SWKS Skyworks Solutions upgraded to Neutral at Mizuho, target $82.97 from $68.85.

$TMCI Treace Medical Concepts holds a Hold rating at Truist, eyeing $9.25 from $3.36.

$TNDM Tandem Diabetes Care maintains Hold at Truist and Equal-Weight at Morgan Stanley, target $22.48 from $17.52.

$TRIP Tripadvisor trades at $15.46, with a Neutral rating and $18.89 upside.

$TSLA Tesla sees a Wall Street price target of $640 from $439.62 current trading.

$TU TELUS remains Equal-Weight at Barclays, target $17.73 from $14.76.

$UEIC Universal Electronics trades at $3.07, with upside to $4.55 from B. Riley’s Neutral outlook.

$VCTR Victory Capital holds Neutral at JP Morgan, targeting $77.21 from $62.42.

$WDC Western Digital surpasses its $170.64 target, trading near $169.97 with upside toward $225.32.

$WEN Wendys has mixed guidance, with targets around $12.88 despite recent cuts to $9 from BofA.

$WSC WillScot Holdings maintains Equal-Weight at Barclays, eyeing $35.31 from $17.95.

$WSM Williams-Sonoma trades at $191.42, with upside to $207.03 under Equal-Weight by Wells Fargo.

$WU Western Union remains Neutral under UBS and Susquehanna with a $9.54 target from $8.91.

$WULF Terawulf sees its price target raised to $26 from $24 at Roth/MKM, trading at $12.37.

$XOM Exxon Mobil lifted to $144 from $141 at Piper Sandler, currently trading at $119.78.

$XPEV XPeng surpasses its target of $24.45, trading at $28.07 with upside to $32.56.

$XRX Xerox holds Neutral at Citigroup with upside to $3.64 from $2.99.

$ZD Ziff Davis trades at $32.27 with a $38.21 target under Citigroup’s Neutral guidance.

View All Headlines